Indian Immunologicals rolls out India’s first indigenously developed Hepatitis A Vaccine ‘Havisure’

Indian Immunologicals has launched Hepatitis A vaccine “Havisure”.

Havisure is effective in preventing the disease and is recommended for children in the routine immunisation. It is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose. The vaccine is also recommended for individuals who are at risk of exposure or travel to the regions with high hepatitis A prevalence. In addition to this people with occupational risk of infection and suffering from chronic liver diseases also need Hepatitis A vaccination.

Dr K Anand Kumar, MD, Indian Immunologicals shared, “Currently Hepatitis A vaccines are imported into our country and as a true meaning of Atma Nirbhar Bharat, IIL has tirelessly put in efforts and developed India’s 1^st vaccine for Hepatitis A. The vaccine Havisure has undergone extensive clinical trials in 8 centers and has proven to be safe and efficacious. The vaccine is comparable to the world’s leading vaccine sold by a multinational. With Havisure, we aim to contribute significantly to the prevention of this infectious disease.”

Dr Priyabrata Pattnaik, Dy. MD, Indian Immunologicals said, “The company has considerably invested in state-of-the-art manufacturing facilities to scale up production and meet the growing demand for Hepatitis A vaccine. As part of the launch, IIL will be collaborating with healthcare professionals, corporate hospitals, and government agencies to promote awareness about Hepatitis A and the importance of both paediatric, adolescent & adult vaccination.”